NYSE Arca · GGRW
Gabelli Growth Innovators ETF financials
$37.59−0.68%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Dec 31 | Q4 '24 Dec 31 | Q4 '23 Dec 31 | Q4 '22 Dec 31 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Gross margin | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| Net margin | — | — | — | — |
| Diluted EPS | — | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — | — |
| Free cash flow | — | — | — | — |
| Diluted shares | 14.8M | 13.2M | 11.7M | 11.1M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $70.6M | $117.1M | $173.9M | $236.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $371.0M | $381.4M | $441.0M | $428.1M |
| Total assets | $601.6M | $700.4M | $834.2M | $873.4M |
| Total liabilities | $493.3M | $523.9M | $585.5M | $574.4M |
| Shareholders' equity | $108.2M | $176.5M | $248.7M | $299.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology